Bellevue Group AG Q1 2018 Filing

Filed May 9, 2018

Portfolio Value

$1.0T

Holdings

124

Report Date

Q1 2018

Filing Type

13F-HR

All Holdings (124 positions)

#StockSharesValue% PortfolioType
101
CAHCARDINAL HEALTH INC
20,000$1.3B0.12%
102
AKCEA THERAPEUTICS INC
48,799$1.3B0.12%
103
RADIUS HEALTH INC
33,300$1.2B0.12%
104
PRTAPROTHENA CORP PLC
30,850$1.1B0.11%
105
EX9EXELIXIS INC
49,800$1.1B0.11%
106
PFEPFIZER INC
29,200$1.0B0.10%
107
CLVSEURCLOVIS ONCOLOGY INC
17,750$937.0M0.09%
108
NVROEURNEVRO CORP
10,700$927.0M0.09%
109
GKOSGLAUKOS CORP
30,000$925.0M0.09%
110
HMS HLDGS CORP
53,500$901.0M0.09%
111
OMCLOMNICELL INC
20,000$868.0M0.09%
112
VAREURVARIAN MED SYS INC
7,000$859.0M0.09%
113
ACADACADIA PHARMACEUTICALS INC
34,550$776.0M0.08%
114
COTIVITI HLDGS INC
21,708$748.0M0.07%
115
MRKMERCK & CO INC
12,500$681.0M0.07%
116
MEDICINES CO
17,600$580.0M0.06%
117
GW PHARMACEUTICALS PLC
4,875$549.0M0.05%
118
CVSCVS HEALTH CORP
8,800$547.0M0.05%
119
SGRYSURGERY PARTNERS INC
31,000$532.0M0.05%
120
QUOTIENT LTD
110,000$518.0M0.05%
121
AAC HLDGS INC
43,700$502.0M0.05%
122
ENDO INTL PLC
62,200$369.0M0.04%
123
MYGNMYRIAD GENETICS INC
11,800$349.0M0.03%
124
AURIS MED HLDG AG
216,963$347.0M0.03%
PreviousPage 2 of 2